The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has directed Abbott ...
Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved a ...
Biocon Biologics gets Health Canada’s nod for Yesintek and Yesintek IV, biosimilars of Stelara used to treat chronic ...
The approval of Yesintek and Yesintek I.V., biosimilars to Stelara, strengthens Biocon Biologics' presence in North America and expands its immunology portfolio ...
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: ...
It took time for Philip to discover acceptance was key to him for living with ALS. Learn about his journey from diagnosis to ...
Biocon Ltd on Thursday said its arm Biocon Biologics Ltd has received an approval from Health Canada for chronic autoimmune ...
This has been a controversial ordinance in the city with some believing it contributes to needle littering in the city.
New long-term extension data show approximately 80% of patients achieved or maintained meaningful skin improvement (EASI 75) with EBGLYSS with half the ...
This valuable study examined the roles of the posterior parietal cortex in rats performing an auditory change-detection decision task. It provided solid evidence for two subpopulations with opposing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback